BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hartnett ME. Advances in understanding and management of retinopathy of prematurity. Surv Ophthalmol 2017;62:257-76. [PMID: 28012875 DOI: 10.1016/j.survophthal.2016.12.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Pekel G, Pekel E. Re: Vogel et al.: Foveal development in infants treated with bevacizumab or laser photocoagulation for retinopathy of prematurity (Ophthalmology. 2018;125:444-452). Ophthalmology 2018;125:e56-7. [PMID: 30032801 DOI: 10.1016/j.ophtha.2018.03.022] [Reference Citation Analysis]
2 Ling K, Liao P, Wang N, Chao A, Chen K, Chen T, Hwang Y, Lai C, Wu W. RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY. Retina 2020;40:1793-803. [DOI: 10.1097/iae.0000000000002663] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Puchwein-Schwepcke A, Grzybowski AK, Genzel-Boroviczény O, Nussbaum C. Effects of Prematurity on the Cutaneous Microcirculatory Network in the First Weeks of Life. Front Pediatr 2019;7:198. [PMID: 31179253 DOI: 10.3389/fped.2019.00198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Nasr VG, Callahan R, Wichner Z, Odegard KC, Dinardo JA. Intraluminal Pulmonary Vein Stenosis in Children: A “New” Lesion. Anesthesia & Analgesia 2019;129:27-40. [DOI: 10.1213/ane.0000000000003924] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
5 Hartnett ME. Discovering Mechanisms in the Changing and Diverse Pathology of Retinopathy of Prematurity: The Weisenfeld Award Lecture. Invest Ophthalmol Vis Sci 2019;60:1286-97. [PMID: 30933256 DOI: 10.1167/iovs.18-25525] [Reference Citation Analysis]
6 Sheibani N, Zaitoun IS, Wang S, Darjatmoko SR, Suscha A, Song YS, Sorenson CM, Shifrin V, Albert DM, Melgar-Asensio I, Kandela I, Henkin J. Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy. Exp Eye Res 2020;195:108030. [PMID: 32272114 DOI: 10.1016/j.exer.2020.108030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Uemura A, Fruttiger M, D'Amore PA, De Falco S, Joussen AM, Sennlaub F, Brunck LR, Johnson KT, Lambrou GN, Rittenhouse KD, Langmann T. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res 2021;:100954. [PMID: 33640465 DOI: 10.1016/j.preteyeres.2021.100954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Han X, Kong J, Hartnett ME, Wang H. Enhancing Retinal Endothelial Glycolysis by Inhibiting UCP2 Promotes Physiologic Retinal Vascular Development in a Model of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci 2019;60:1604-13. [PMID: 30995317 DOI: 10.1167/iovs.19-26553] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lenis TL, Gunzenhauser RC, Fung SSM, Dhindsa YK, Sarraf D, Pineles SL, Tsui I. Myopia and anterior segment optical coherence tomography findings in laser-treated retinopathy of prematurity eyes. J AAPOS 2020;24:86.e1-7. [PMID: 32224286 DOI: 10.1016/j.jaapos.2020.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Zeng Y, Ge G, Lei C, Zhang M. Beyond Fetal Immunity: A Systematic Review and Meta-Analysis of the Association Between Antenatal Corticosteroids and Retinopathy of Prematurity. Front Pharmacol 2022;13:759742. [DOI: 10.3389/fphar.2022.759742] [Reference Citation Analysis]
11 Macor S, Pignatto S, Capone A Jr, Piermarocchi S, Lanzetta P. Lens-sparing vitrectomy for stage 4A retinopathy of prematurity in infants with aggressive-posterior ROP: Anatomic and functional results. Eur J Ophthalmol 2021;31:2020-6. [PMID: 32755238 DOI: 10.1177/1120672120946938] [Reference Citation Analysis]
12 Rojas MA, Shen ZT, Caldwell RB, Sigalov AB. Blockade of TREM-1 prevents vitreoretinal neovascularization in mice with oxygen-induced retinopathy. Biochim Biophys Acta Mol Basis Dis 2018;1864:2761-8. [PMID: 29730341 DOI: 10.1016/j.bbadis.2018.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang J, Zhang Q, Chen E, Zhao P, Xu Y. Elabela promotes the retinal angiogenesis by inhibiting ferroptosis during the vaso-obliteration phase in mouse oxygen-induced retinopathy model. FASEB J 2022;36:e22257. [PMID: 35471770 DOI: 10.1096/fj.202101785RRR] [Reference Citation Analysis]
14 Li K, Li R, Zou P, Li L, Wang H, Kong D, Zheng G, Li LL. Glycopeptide-nanotransforrs eyedrops with enhanced permeability and retention for preventing fundus neovascularization. Biomaterials 2022;281:121361. [PMID: 34991034 DOI: 10.1016/j.biomaterials.2021.121361] [Reference Citation Analysis]
15 Yang R, Ding H, Shan J, Li X, Zhang J, Liu G, Zheng H, Su Y, Yao H, Qi K. Association of fish oil containing lipid emulsions with retinopathy of prematurity: a retrospective observational study. BMC Pediatr 2022;22:113. [PMID: 35236316 DOI: 10.1186/s12887-022-03174-9] [Reference Citation Analysis]
16 Michel S, Reynaud C, Daruich A, Hadj-Rabia S, Bremond-Gignac D, Bodemer C, Robert MP. Early management of sight threatening retinopathy in incontinentia pigmenti. Orphanet J Rare Dis 2020;15:223. [PMID: 32854719 DOI: 10.1186/s13023-020-01509-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mangalesh S, Bleicher ID, Chen X, Viehland C, LaRocca F, Izatt JA, Freedman SF, Hartnett ME, Toth CA. Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2019;257:677-88. [PMID: 30790072 DOI: 10.1007/s00417-019-04274-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Dogra M, Singh SR. Commentary: Looking beyond anti-vascular endothelial growth factor - Novel therapeutic targets for retinopathy of prematurity. Indian J Ophthalmol 2021;69:374-5. [PMID: 33463596 DOI: 10.4103/ijo.IJO_3272_20] [Reference Citation Analysis]
19 Zhong DJ, Zhang Y, Zhang S, Ge YY, Tong M, Feng Y, You F, Zhao X, Wang K, Zhang L, Liu X, Chen JF. Adenosine A2A receptor antagonism protects against hyperoxia-induced retinal vascular loss via cellular proliferation. FASEB J 2021;35:e21842. [PMID: 34418159 DOI: 10.1096/fj.202100414RR] [Reference Citation Analysis]
20 Lee Y, See L, Chang S, Wang N, Hwang Y, Lai C, Chen K, Wu W. Macular Structures, Optical Components, and Visual Acuity in Preschool Children after Intravitreal Bevacizumab or Laser Treatment. American Journal of Ophthalmology 2018;192:20-30. [DOI: 10.1016/j.ajo.2018.05.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
21 Shukla R, Murthy GVS, Gilbert C, Vidyadhar B, Mukpalkar S. Operational guidelines for ROP in India: A summary. Indian J Ophthalmol 2020;68:S108-14. [PMID: 31937744 DOI: 10.4103/ijo.IJO_1827_19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
22 Becker S, Wang H, Simmons AB, Suwanmanee T, Stoddard GJ, Kafri T, Hartnett ME. Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms. Sci Rep 2018;8:2003. [PMID: 29386650 DOI: 10.1038/s41598-018-20278-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
23 Katargina LA, Chesnokova NB, Beznos OV, Osipova NA, Panova AY. [Pathogenetically oriented approach to prevention of retinopathy of prematurity (experimental study)]. Vestn Oftalmol 2021;137:26-31. [PMID: 34156775 DOI: 10.17116/oftalma202113703126] [Reference Citation Analysis]
24 Yu Y, Wang J, Chen F, Chen W, Jiang N, Xiang D. Study protocol for prognosis and treatment strategy of peripheral persistent avascular retina after intravitreal anti-VEGF therapy in retinopathy of prematurity. Trials 2020;21:493. [PMID: 32513245 DOI: 10.1186/s13063-020-04371-6] [Reference Citation Analysis]
25 Rahimi M, Leahy S, Blair NP, Shahidi M. Variability of Retinal Oxygen Metrics in Healthy and Diabetic Subjects. Transl Vis Sci Technol 2021;10:20. [PMID: 34661625 DOI: 10.1167/tvst.10.12.20] [Reference Citation Analysis]
26 Calvo CM, Hartnett ME. The utility of ultra-widefield fluorescein angiography in pediatric retinal diseases. Int J Retina Vitreous 2018;4:21. [PMID: 29992045 DOI: 10.1186/s40942-018-0122-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
27 Wang Y, Wang X, Wang YX, Ma Y, Di Y. Effect and mechanism of the long noncoding RNA MALAT1 on retinal neovascularization in retinopathy of prematurity. Life Sci 2020;260:118299. [PMID: 32827542 DOI: 10.1016/j.lfs.2020.118299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Sahinoglu-Keskek N, Akkoyun I, Torer B. Favorable outcomes in the treatment of aggressive posterior retinopathy of prematurity. Eur J Ophthalmol 2021;31:179-83. [PMID: 31718282 DOI: 10.1177/1120672119886989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Tong Q, Yin H, Zhao M, Li X, Yu W. Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab. BMC Ophthalmol 2018;18:150. [PMID: 29940900 DOI: 10.1186/s12886-018-0815-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
30 Ittarat M. Comparison of Outcomes Between Combined Sparing Laser Photocoagulation and Intravitreal Bevacizumab Treatment Versus Conventional Laser Photocoagulation in Aggressive Posterior Retinopathy of Prematurity. J Pediatr Ophthalmol Strabismus 2021;:1-6. [PMID: 34180288 DOI: 10.3928/01913913-20210316-01] [Reference Citation Analysis]
31 Sigalov AB. Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old. Adv Protein Chem Struct Biol 2018;111:61-99. [PMID: 29459036 DOI: 10.1016/bs.apcsb.2017.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
32 Fevereiro-Martins M, Guimarães H, Marques-Neves C, Bicho M. Retinopathy of prematurity: contribution of inflammatory and genetic factors. Mol Cell Biochem 2022. [PMID: 35262882 DOI: 10.1007/s11010-022-04394-4] [Reference Citation Analysis]
33 Wintergerst MWM, Petrak M, Li JQ, Larsen PP, Berger M, Holz FG, Finger RP, Krohne TU. Non-contact smartphone-based fundus imaging compared to conventional fundus imaging: a low-cost alternative for retinopathy of prematurity screening and documentation. Sci Rep 2019;9:19711. [PMID: 31873142 DOI: 10.1038/s41598-019-56155-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
34 Di Y, Chen XL. Effects of LY294002 on the function of retinal endothelial cell in vitro. Int J Ophthalmol 2018;11:1447-50. [PMID: 30225216 DOI: 10.18240/ijo.2018.09.03] [Reference Citation Analysis]
35 Podraza W. A new approach to neonatal medical management that could transform the prevention of retinopathy of prematurity: Theoretical considerations. Med Hypotheses 2020;137:109541. [PMID: 31901610 DOI: 10.1016/j.mehy.2019.109541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Iwahashi C, Utamura S, Kuniyoshi K, Sugioka K, Konishi Y, Wada N, Kusaka S. FACTORS ASSOCIATED WITH REACTIVATION AFTER INTRAVITREAL BEVACIZUMAB OR RANIBIZUMAB THERAPY IN INFANTS WITH RETINOPATHY OF PREMATURITY. Retina 2021;41:2261-8. [PMID: 33958533 DOI: 10.1097/IAE.0000000000003196] [Reference Citation Analysis]
37 Kumawat D, Sachan A, Shah P, Chawla R, Chandra P. Aggressive posterior retinopathy of prematurity: a review on current understanding. Eye (Lond) 2021;35:1140-58. [PMID: 33514899 DOI: 10.1038/s41433-021-01392-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Zhang T, Wang Z, Sun L, Li S, Huang L, Liu C, Chen C, Luo X, Yu B, Ding X. Ultra-wide-field scanning laser ophthalmoscopy and optical coherence tomography in FEVR: findings and its diagnostic ability. Br J Ophthalmol 2021;105:995-1001. [PMID: 32788330 DOI: 10.1136/bjophthalmol-2020-316226] [Reference Citation Analysis]
39 Dame C, Sciesielski LK, Rau C, Badur C, Bührer C. The Erythropoietin Promoter Variant rs1617640 Is Not Associated with Severe Retinopathy of Prematurity, Independent of Treatment with Erythropoietin. The Journal of Pediatrics 2018;199:256-9. [DOI: 10.1016/j.jpeds.2018.03.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Tsang JKW, Wolf SA, Pompoes IM, Joussen AM, Lam WC, Yang D, Lo ACY. Potential Effects of Nutraceuticals in Retinopathy of Prematurity. Life (Basel) 2021;11:79. [PMID: 33499180 DOI: 10.3390/life11020079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wintergerst MW, Jansen LG, Holz FG, Finger RP. Smartphone-Based Fundus Imaging–Where Are We Now? Asia-Pacific Journal of Ophthalmology 2020;9:308-14. [DOI: 10.1097/apo.0000000000000303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Hartnett ME, Toth CA. Experimental Evidence Behind Clinical Trial Outcomes in Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina 2019;50:228-34. [PMID: 30998244 DOI: 10.3928/23258160-20190401-05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Jansen LG, Schultz T, Holz FG, Finger RP, Wintergerst MWM. [Smartphone-based fundus imaging: applications and adapters]. Ophthalmologe 2021. [PMID: 34913992 DOI: 10.1007/s00347-021-01536-9] [Reference Citation Analysis]
44 Berrocal AM, Fan KC, Al-Khersan H, Negron CI, Murray T. Retinopathy of Prematurity: Advances in the Screening and Treatment of Retinopathy of Prematurity Using a Single Center Approach. Am J Ophthalmol 2021:S0002-9394(21)00383-4. [PMID: 34298009 DOI: 10.1016/j.ajo.2021.07.016] [Reference Citation Analysis]
45 Pereira-Figueiredo D, Nascimento AA, Cunha-Rodrigues MC, Brito R, Calaza KC. Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors. Cell Mol Neurobiol 2021. [PMID: 33730305 DOI: 10.1007/s10571-021-01077-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Simmons AB, Fuerst PG. Analysis of Retinal Vascular Plexuses and Interplexus Connections. Methods Mol Biol 2018;1753:317-30. [PMID: 29564799 DOI: 10.1007/978-1-4939-7720-8_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Wang J, Liu C, Wu H, Ng TK, Zhang M. Diagnostic Accuracy of Wide-Field Digital Retinal Images in Retinopathy of Prematurity Detection: Systematic Review and Meta-Analysis. Curr Eye Res 2022;:1-10. [PMID: 35435102 DOI: 10.1080/02713683.2022.2050262] [Reference Citation Analysis]
48 Kennedy KA, Mintz-Hittner HA; BEAT-ROP Cooperative Group. Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity. J AAPOS 2018;22:61-65.e1. [PMID: 29223789 DOI: 10.1016/j.jaapos.2017.10.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
49 Zhu Z, Hua X, Yu Y, Zhu P, Hong K, Ke Y. Effect of red blood cell transfusion on the development of retinopathy of prematurity: A systematic review and meta-analysis. PLoS One 2020;15:e0234266. [PMID: 32512582 DOI: 10.1371/journal.pone.0234266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
50 Sizmaz S, Esen E, Gorkemli N, Sariyeva A, Demircan N. Outcome of 532 nm Nd:YAG laser photocoagulation in retinopathy of prematurity from a referral center. Clin Exp Optom 2021;104:518-22. [PMID: 33689612 DOI: 10.1080/08164622.2021.1878818] [Reference Citation Analysis]
51 Deng Y, Li S, Li S, Yu C, Huang D, Chen H, Yin X. CircPDE4B inhibits retinal pathological angiogenesis via promoting degradation of HIF-1α though targeting miR-181c. IUBMB Life 2020;72:1920-9. [PMID: 32584521 DOI: 10.1002/iub.2307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Costet C, Renesme L, Tandonnet O, Korobelnik JF, Andrèbe C, Paya C, Coste V. Retinopathy of prematurity associated with oculocutaneous albinism: Laser treatment is not an option. J Fr Ophtalmol 2019;42:e333-4. [PMID: 31133397 DOI: 10.1016/j.jfo.2018.11.020] [Reference Citation Analysis]
53 Kondo C, Iwahashi C, Utamura S, Kuniyoshi K, Konishi Y, Wada N, Kawasaki R, Kusaka S. Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. Front Pediatr 2022;10:785292. [DOI: 10.3389/fped.2022.785292] [Reference Citation Analysis]